Clinical Trial Update: A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma

View source ↗

Summary

A non-interventional pilot study update evaluating whether LOXL2 is present in subjects with systemic sclerosis (limited and diffuse forms).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis Diffuse
• Systemic Sclerosis Limited

Snippet

Sponsor: Gilead Sciences | Conditions: Limited Scleroderma, Diffuse Scleroderma | Status: COMPLETED